Emerging Approaches in AMD and DME: A Case-Based Discussion

home / state-of-sciences-presentations / emerging-approaches-in-amd-and-dme-a-case-based-discussion

Experts share clinical perspective and practical insights regarding current challenges and opportunities in the management of patients with age-related macular degeneration or diabetic macular edema, in highlights from a recent State of the Science Summit^TM, presented by HCP Live®

Steven Schwartz discusses data showing the average amount of injections patients receive per year.

EP. 1: Overview of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Steven D. Schwartz, MD

October 11th 2023

Steven D. Schwartz, MD, reviews challenges and unmet needs in treatment of patients with neovascular AMD and DME.

Single-dose faricimab in treatment-experiences eyes with nARMD: Case 1

EP. 2: Single-dose faricimab in treatment-experiences eyes with nARMD: Case 1

Moritz Pettenkofer, MD

October 11th 2023

Moritz Pettenkofer, MD, discusses the mechanisms of faricimab and presents a case study of a 66-year-old female with nARMD

Single-dose faricimab in treatment-experiences eyes with nARMD: Case 2

EP. 3: Single-dose faricimab in treatment-experiences eyes with nARMD: Case 2

Moritz Pettenkofer, MD

October 11th 2023

Moritz Pettenkofer, MD, presents a case of a 75-year-old male patient with nARMD who has had 53 injections of anti-VEGF therapy over 4 years.

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.